Physician profile
Jacob Modest
NPI 1518458371
$42,703.68
in general payments reported to CMS, 2019-2025
7 companies · $11K in 2025
The $11K reported for 2025 was more than what 88% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $152 · 2020: $35.47 · 2021: $553 · 2022: $163 · 2023: $2,284 · 2024: $29K · 2025: $11K.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Grant: $33K · Travel and Lodging: $4,615 · Food and Beverage: $3,498 · Education: $354.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Grant | $33,333.34 |
| Travel and Lodging | $4,614.86 |
| Food and Beverage | $3,498.20 |
| Education | $354.04 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Arthrex, INC. | $21,179.80 | 2024-2025 | |
| Smith+Nephew, INC. | $15,224.96 | 2024-2025 | Double Endobutton, Healicoil, Coblation |
| Stryker Corporation | $3,578.84 | 2019-2025 | Blueprint Patient Specific Instrumentation, Salvation, T2 Alpha |
| Zimmer Biomet Holdings, INC. | $2,231.71 | 2020-2024 | Affixus, Ncb, Xtrafix |
| Polaris Technology Solutions LLC | $243.09 | 2025 | |
| Joint Restoration Foundation, INC. | $123.25 | 2025 | |
| Vericel Corporation | $122.03 | 2025 | Maci |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jacob Modest listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.